Streetbeat News

Stock Prices

SNAP

Snap shares are trading higher without any company-specific news driving the increase.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 4:52 pm

DTRUY

TM

Toyota Motor Corp (NYSE:TM) is reportedly planning to shift its focus to selling hydrogen-powered trucks and cars in Europe and China, as part of its ambition to sell 200,000 hydrogen fuel-cell vehicles by 2030. This marks a shift in the automaker's growth focus from passenger cars sales and the North American market. Toyota and Daimler Truck Holding (OTC:DTRUY) have collaborated on developing hydrogen and other CASE technologies. Toyota expects the global fuel cells market growth to be about $35 billion by 2030.

Portfolio Pulse from Shivani Kumaresan

July 11, 2023 | 4:51 pm

TNDM

Tandem Diabetes Care has received FDA clearance for its Tandem Mobi insulin pump, leading to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 4:51 pm

GSK

NNVC

PFE

NanoViricides Inc (NNVC) shares are trading higher after the company reported positive preclinical data for its antiviral clinical drug candidate NV-387 for Respiratory Syncytial Virus (RSV). NV-387 is also the active ingredient of NV-CoV-2, the company's drug for COVID. The company plans to advance NV-387 into Phase 2 studies against RSV once the current Phase 1 studies of NV-CoV-2 are completed. GSK plc's (GSK) Arexvy and Pfizer Inc's (PFE) Abrysvo have recently been approved for RSV prophylaxis.

Portfolio Pulse from Vandana Singh

July 11, 2023 | 4:51 pm

RDFN

Redfin shares are trading higher in sympathy with Zillow following a positive analyst note from Piper Sandler.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 4:50 pm

ADIL

Adial Pharmaceuticals Inc's shares are trading higher after the company provided a summary of feedback from recent meetings with U.S. and EU regulators and an update on its clinical development plan. The regulators confirmed the primary U.S. endpoint and acknowledged the results from the Phase 2 and Phase 3 post hoc analysis. The FDA agreed to Adial's plan to comply with ICH E1A by adding a long-term safety follow-up to the planned Phase 3 trial. The company expects to register AD04 with the FDA in Q3 of 2025, with an approximate cost of $25 million.

Portfolio Pulse from Vandana Singh

July 11, 2023 | 4:48 pm

BGNE

NVS

BeiGene Limited (NASDAQ:BGNE) shares are trading lower after the company mutually agreed to terminate a licensing deal with Novartis A/S (NYSE:NVS) and regained global rights to develop, manufacture and commercialize ociperlimab. The companies are also collaborating to develop another oncology candidate, tislelizumab, with Novartis securing development and commercialization rights in North America, Europe, and Japan.

Portfolio Pulse from Vandana Singh

July 11, 2023 | 4:45 pm

BYRN

Byrna Technologies reported worse-than-expected Q2 financial results and withdrew its fiscal year 2023 guidance, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 4:44 pm

F

TSLA

Jim Cramer, host of 'Mad Money', has criticized Tesla's Cybertruck, calling it a 'monstrosity' and a 'toy for Elon Musk fanboys'. He praised Ford's F-150 Lightning, which he considers superior. Cramer owns Ford stock for his charitable trust and expects sales of the F-150 Lightning to outpace the Cybertruck. Tesla's Cybertruck is set to begin production later this year with deliveries expected in the third quarter.

Portfolio Pulse from Adam Eckert

July 11, 2023 | 4:44 pm

SYTA

Siyata Mobile has announced the pricing of a registered direct offering worth approximately $2.3 million, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 4:43 pm